Does Intermittent Fasting Help a Fatty Liver? What the Trials Show

Fasting is widely recommended for liver health, usually on the theory that the liver needs a rest. The evidence now runs to nineteen randomised trials, and it answers two questions that get collapsed into one: whether fasting works, and whether it works better than simply eating less.

TL;DR

• Fasting does reduce liver fat. In a 337-person trial of people with diagnosed fatty liver disease, time-restricted eating cut liver fat by 25.8% over sixteen weeks, against a 0.7% increase on standard care.
• It didn't beat ordinary calorie restriction. In the same trial, calorie restriction achieved 24.7%, with no significant difference between them.
• A 2026 meta-analysis of nine trials agrees. Fasting showed no advantage over continuous calorie restriction on MRI-measured liver fat, liver stiffness or liver enzymes. It did produce 1.29 kg more weight loss.
• A network meta-analysis of nineteen trials ranked fasting highly for reducing liver fat, with alternate-day fasting best for weight and insulin resistance — though rankings compare regimens rather than prove superiority.
• Eight-hour windows showed no additional liver-fat benefit in two 2026 trials, over and above Mediterranean-diet and activity advice — and early, late and self-chosen windows performed alike.
• No effect on scarring has been shown. No fasting approach improved liver stiffness in any trial or review — though stiffness is an indirect measure, and these trials were too short to test fibrosis properly.
• So fasting is a credible option, not a special one. No liver-specific benefit beyond other effective diets has been demonstrated, which makes the best regimen the one you can keep up.

Two different questions, often confused

Fatty liver disease — now metabolic dysfunction-associated steatotic liver disease, or MASLD — affects an estimated one in four UK adults, most of whom don't know it, because it produces no symptoms until it's advanced. It's driven by insulin resistance and by how the body stores surplus energy, which makes it an obvious target for anything that reduces how much people eat.

Fasting arrived into that gap with a mechanism attached: that a long overnight gap lets the liver switch from storing fat to burning it. But a mechanism tells you nothing about the size of the effect, or whether it's specific to fasting. Hence two tangled questions — "does fasting improve my liver?" and "is fasting better than other ways of eating less?" — which have different answers.

Does fasting reduce liver fat? Yes, clearly

The strongest single piece of evidence is a trial published in the Journal of Hepatology, which did something the others didn't: it recruited people who had the condition.

It randomised 337 patients with overweight or obesity and diagnosed MASLD into three equal groups for sixteen weeks — standard of care, calorie restriction, or an eight-hour eating window from 10am — with 333 in the full analysis. The primary endpoint was hepatic steatosis measured by MRI proton density fat fraction, the most reliable non-invasive measure available.

Liver fat fell by 25.8% in the fasting group and rose by 0.7% on standard care, significant at p < 0.001. The fasting group also saw greater reductions in body weight, waist circumference and body fat mass.

An earlier trial points the same way. In 2021, 74 people with fatty liver disease were randomised to a 5:2 diet, a low-carbohydrate high-fat diet, or general lifestyle advice. Liver fat fell 6.1% on 5:2 and 7.2% on low-carb against 3.6% on standard advice, with weight down about 7.4 kg on both diets against 2.5 kg.

One thing to watch when comparing these numbers: the 25.8% is a relative reduction, roughly a quarter of the fat present at the start. The 2021 trial reports absolute reductions — percentage points of liver fat — and the trials in the next section report between-group differences in percentage points. A 25.8% relative fall and a 0.4 percentage-point difference are not on the same scale and shouldn't be read against each other. With that said, the first question has a clear answer: take up a fasting pattern that reduces what you eat, and the fat in your liver is likely to fall by a clinically meaningful amount.

Does it beat simply eating less? No

The same trial answers the second question, and the answer is no. The calorie restriction group achieved a 24.7% reduction in liver fat against the fasting group's 25.8%, with a p-value above 0.999 — meaning the trial found no significant advantage for fasting. That is worth stating precisely: failing to find a difference is not the same as proving equivalence, which takes a trial designed to test it. What this establishes is that fasting did not come out ahead. Liver stiffness, glucose control and sleep quality were also comparable.

A systematic review published in Frontiers in Nutrition in May 2026 pooled nine randomised trials and 894 participants with fatty liver disease, comparing intermittent fasting directly against continuous calorie restriction. On MRI-measured liver fat, the difference was −0.08% (95% CI −1.65 to 1.48) — nothing. Liver stiffness showed no difference (−0.41 kPa, −1.07 to 0.25), nor did ALT or AST.

Fasting did show two advantages. It produced 1.29 kg more weight loss (95% CI −1.98 to −0.61), and on FibroScan CAP — an ultrasound-based estimate of liver fat — it looked better by 15.13 dB/m (−28.87 to −1.39). But the authors are careful about that second result, and so should anyone citing it be: the CAP finding wasn't confirmed by the MRI measure, and it lost statistical significance in sensitivity analysis, falling to −11.97 dB/m with an interval running from −31.08 to 7.14. Only two of the nine trials were rated low risk of bias.

A network meta-analysis in Clinical Nutrition ESPEN reached a more favourable verdict, pooling nineteen trials and 1,149 participants. It ranked time-restricted feeding most effective for reducing hepatic steatosis at a mean difference of −23.32 dB/m, with alternate-day fasting producing the largest reductions in weight, waist circumference and body fat, and being the only regimen to significantly improve insulin resistance. Both 5:2 and time-restricted feeding reduced liver enzymes.

Two caveats keep that in proportion. The steatosis figure is again CAP rather than MRI, and a network meta-analysis ranks approaches across indirect comparisons rather than head-to-head tests, so a top ranking is a reasonable bet rather than proof. Both reviews also searched the literature before the two trials below were published.

Does the eating window itself do anything?

Two trials from the same Spanish research group tested the window as an isolated variable, using MRI, with every group receiving the same dietary education.

The first, in JHEP Reports, randomised 197 adults with overweight or obesity into four groups for twelve weeks: usual care based on Mediterranean-diet education, or that same programme plus an eight-hour window placed early, late, or wherever the participant chose. Liver fat fell within all three fasting groups, but none differed from usual care — early −0.4% (p = 0.95), late −1.5% (p = 0.15), self-selected −0.7% (p = 0.77) — and none differed from each other, at p ≥ 0.41. Liver markers and gut bacteria showed no differences either.

The second was TEMPUS, in Nature Communications in October 2026: 187 adults with obesity randomised for twelve weeks to an eight-hour window, supervised exercise, both, or usual care. Against usual care, the window gave −0.4% (95% CI −2.0 to 1.2, p = 0.93), exercise −0.8% (−2.4 to 0.8, p = 0.54), and both together −1.1% (−2.7 to 0.5, p = 0.28).

Neither trial recruited people for liver disease, both ran twelve weeks, and they share a research group, so they aren't independent replications. But one detail is instructive: the fasting groups lost more weight, with 41 to 44% achieving at least 5% weight loss against 16% on usual care, and those who lost 5% had liver fat reductions around 2.6 percentage points larger. So fasting produced greater weight loss — and that still didn't translate into a statistically significant additional reduction in liver fat for the fasting groups as a whole.

What hasn't been shown

One result is consistent across every trial and both reviews, and it's the one most often glossed over: no fasting regimen improved liver stiffness. The 337-person trial found it comparable between fasting and calorie restriction, the Frontiers review found no difference, and the network meta-analysis said plainly that none of the regimens improved it.

That is easy to over-claim in either direction. Stiffness measured by elastography is an indirect proxy for scarring rather than scarring itself, and twelve to sixteen weeks is reasonable for liver fat but nowhere near long enough to test fibrosis. Fasting has not been shown to reverse scarring — which is not the same as showing it cannot.

What This Actually Means

If you have fatty liver and want to use a fasting pattern, the evidence supports you: it works, it's been tested in people with the diagnosis, and the effect size is substantial. No serious adverse events were reported in the sixteen weeks of the 337-person trial, which is reassuring without establishing long-term safety for everyone.

What the evidence doesn't support is choosing fasting because it's fasting. Against calorie restriction it has not come out ahead, and the window's placement made no measurable difference — which sits awkwardly with the circadian repair story the practice is usually sold with. Note the careful wording: no liver-specific benefit beyond other effective diets has been demonstrated. That is not the same as proving fasting has no mechanism of its own, only that nobody has shown one in these outcomes. The practical edge is real, though — the 5:2 group in the 2021 trial tolerated their diet better than the low-carb group, and adherence is not a trivial advantage.

The corollary is the useful bit: if you're fasting and nothing is changing, the window isn't the problem — what's inside it is. What tracked with improvement across the 2026 trials was losing weight and eating fewer ultra-processed foods.

Fasting also isn't for everyone. If you take any medicine that can lower your blood sugar, if you are pregnant, or if you have a current or past eating disorder, speak to your GP before adopting an eating window rather than starting one on the strength of an article.

Frequently Asked Questions

Does 16:8 fasting reduce liver fat?

Yes. In a 337-person trial of people with diagnosed fatty liver disease, an eight-hour eating window starting at 10am reduced MRI-measured liver fat by 25.8% relative to baseline over sixteen weeks, against a 0.7% increase on standard care. It did not do better than calorie restriction.

Is fasting better than just cutting calories?

No advantage has been shown. A 2026 review of nine trials found no difference on MRI-measured liver fat, stiffness or liver enzymes, though fasting produced about 1.29 kg more weight loss.

Does the time of day I eat matter?

Not on current evidence. A 2026 trial of 197 adults compared early, late and self-selected eight-hour windows and found no difference between them, or between any of them and ordinary Mediterranean-diet advice.

Which type of fasting is best?

A network meta-analysis of nineteen trials ranked time-restricted feeding highest for liver fat and alternate-day fasting best for weight and insulin resistance — but rankings built from indirect comparisons aren't proof of superiority.

Can fasting reverse liver scarring?

It hasn't been shown to. No trial or review found an improvement in liver stiffness, but stiffness is an indirect measure of scarring and these trials ran only twelve to sixteen weeks — too short to test fibrosis either way.

The Bottom Line

Fasting reduces liver fat — well enough established now, including in people who have the diagnosis rather than just the risk factors, to state without hedging.

What remains unproven is that restricting when you eat produces consistently greater liver benefit than other effective diets. Calorie restriction matched it in the best trial available, the window's placement made no measurable difference, and no effect on scarring has been shown. So for most adults the decision comes down to which approach they can sustain rather than whether the liver needs a prescribed rest — though medical circumstances can change whether fasting suits you at all. Our Liver Reset covers the rest, including what the blood tests do and don't tell you.

This article is for general information and is not medical advice. If you have risk factors for liver disease or an abnormal blood test result, speak to your GP.

Sources

• Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease. Journal of Hepatology, 2025. https://www.journal-of-hepatology.eu/article/S0168-8278(25)02272-X/abstract
• Li H, Li T. Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis. Frontiers in Nutrition, 2026;13:1833688. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1833688/full
• Abu Suilik H, Gadelmawla AF, Rifai M, et al. Intermittent fasting strategies for metabolic dysfunction-associated steatotic liver disease: a systematic review and frequentist network meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN, 2026. https://pubmed.ncbi.nlm.nih.gov/42342126/
• Dote-Montero M, Clavero-Jimeno A, Cortés-Martín A, et al. Time-restricted eating, liver health, and fecal microbiota in adults with overweight or obesity: a randomized controlled trial. JHEP Reports, 2026. https://pubmed.ncbi.nlm.nih.gov/42413768/
• Clavero-Jimeno A, et al. Effects of time-restricted eating and supervised exercise on intrahepatic fat and cardiometabolic health in adults with obesity: the TEMPUS randomized controlled trial. Nature Communications, 2026. https://www.nature.com/articles/s41467-026-78625-3
• Holmer M, Lindqvist C, Petersson S, et al. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet — a randomised controlled trial. JHEP Reports, 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8059083/
• Bo S, Armandi A, Castelnuovo G, et al. Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: a randomized controlled trial. JHEP Reports, 2026. https://pubmed.ncbi.nlm.nih.gov/42331287/
• Millions living with fatty liver disease without knowing it, UK study suggests. Liver UK, October 2026. https://liveruk.org/millions-living-with-fatty-liver-disease-without-knowing-it-uk-study-suggests/